Fundz

Biohaven Ltd. Appoints David Pirman as Executive Vice President and Head of Discovery

PUBLIC · BHVNJul 09, 2026
Internal move“Dr. David Pirman has been promoted to Executive Vice President and Head of Discovery”

Position

Executive Vice President

Company

Biohaven

David Pirman, Ph.D.
New HavenBiotechnologyHealth CareTherapeutics

Description

On July 9, 2026, Biohaven Ltd. announced the retirement of Dr. Bruce Car from his role as Chief Scientific Officer to become Chief Innovation Officer

Quick answer

Biohaven Ltd. Appoints David Pirman as Executive Vice President and Head of Discovery (July 9, 2026). Biohaven is based in New Haven, Connecticut, United States.

What did Biohaven announce on July 9, 2026?
On July 9, 2026, Biohaven Ltd. announced the retirement of Dr. Bruce Car from his role as Chief Scientific Officer to become Chief Innovation Officer
What does Biohaven do?
Biohaven is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including...
Where is Biohaven based?
Biohaven is based in New Haven, Connecticut, United States.
Which similar companies made leadership changes around the same time?
Foresee Pharmaceuticals (July 9, 2026), Immunocine Cancer Center (July 7, 2026), Acadia Pharmaceuticals (July 6, 2026) and Stoke Therapeutics, Inc. (July 13, 2026) also announced leadership changes within 45 days of Biohaven.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Biohaven, and when

A new leader at Biohaven brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Biohaven raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biohaven, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biohaven. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biohaven

Location

New Haven, Connecticut, United States

About

Biohaven is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Biohaven’s Neuroinnovation™ portfolio includes FDA-approved NURTEC® ODT (rimegepant) for the acute and preventive treatment of migraine (EMA-approved as Vydura® for the acute treatment of migraine with or without aura, and prophylaxis of episodic migraine in adults who have at least four migraine attacks per month) and a broad pipeline of late-stage product candidates across five distinct mechanistic platforms: CGRP receptor antagonism for the acute and preventive treatment of migraine; glutamate modulation for obsessive-compulsive disorder, and spinocerebellar ataxia; myeloperoxidase (MPO) inhibition for amyotrophic lateral sclerosis; Kv7 ion channel activators for focal epilepsy and neuronal hyperexcitability, and myostatin inhibition for neuromuscular diseases. More information about Biohaven is available at www.biohavenpharma.com and NURTEC® ODT at www.nurtec.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biohaven changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Vlad
Likely contact at this company
••••••••@••••••••

See Vlad's verified email →

Bruce
Senior decision-maker at this company
••••••••@••••••••

See Bruce's verified email →

Matt
Senior decision-maker at this company
••••••••@••••••••

See Matt's verified email →

Camille
Likely contact at this company
••••••••@••••••••

See Camille's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Biohaven's next move

Learn about Strategic plan

Biohaven changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.